Ebola: Promising Early-Stage Safety Clinical Trial Results For Potential Treatment Based On Antibodies Isolated In Switzerland

25 gennaio 2019

Gabriel Haering al Career Chat presso l’ETH di Zurigo

17 gennaio 2019

Augusto Mitidieri, Best CEO in the Pain Management Industry

12 dicembre 2018

Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)

3 dicembre 2018

PKU GOLIKE® comes to fruition in Italy

29 novembre 2018

La farmaceutica ticinese a Madrid per la CPhI 2018

28 novembre 2018

Paolo Magri nominated as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)

14 novembre 2018

Consegnato il premio di miglior sportivo ticinese dell’anno 2018

6 novembre 2018

Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU management. PKU GOLIKE® by APR can play a role

6 novembre 2018

Helsinn Group supports Satellite Symposium at 14th EADO Congress 2018

6 novembre 2018